查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197834

器官護理系統 (OCS) 市場——增長、趨勢和預測 (2023-2028)

Organ Care Systems (OCS) Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

研究中的器官護理系統 (OCS) 市場預計在預測期內以 9.1% 的複合年增長率增長。

COVID-19 的突然爆發對市場產生了重大影響。 這主要是由於為遏制大流行感染而取消的擇期手術導致器官捐獻和移植手術減少。 2021 年 12 月發表在 Springer 上的一篇論文指出，器官捐贈減少了 21%，移植減少了 59%。 同一消息來源還指出，由於 COVID-19 大流行，59% 的活體腎臟移植計劃已暫停對新捐贈者的評估。 大流行期間器官捐贈和移植的這種下降對市場增長產生了重大影響。 然而，大流行後嚴格監管的放鬆導致器官捐贈和移植手術的增加，有助於預測期內的市場增長。

市場增長的重要推動力包括導致器官衰竭的各種慢性病發病率不斷上升，以及器官移植手術的數量不斷增加。 技術發展的進步也有望促進市場增長。

同樣，根據英國心臟基金會2022年8月公佈的數據，2021年英國將有超過760萬人戰勝心臟或循環系統疾病。 2022年3月發布的世界腎臟日數據提到，全球約十分之一的人患有慢性腎髒病。 預計導致器官移植的各種疾病的流行將有助於市場的增長。 此外，大量器官移植也被認為是市場增長的推動力。 例如，Print 在 2022 年 5 月發布的數據指出，印度每年進行近 17,000 至 18,000 例實體器官移植。

此外，預計各主要市場參與者增加產品批准和發布也將有助於市場增長。 2021 年 12 月，OrganOx 獲得了美國 FDA 對 metra 系統的上市前批准。 metra 是一種全自動 NMP 設備，用於儲存和運輸供體肝臟以供移植。

因此，預計器官移植手術需求的增加以及產品的批准和開發將有助於預測期內的市場增長。

器官護理系統 (OCS) 市場趨勢

心臟部分有望佔據較大的市場份額

研究領域的增長歸因於心血管疾病發病率的上升和世界人口中心臟移植的增加。

例如，美國心臟雜誌 2021 年 5 月發布的數據指出，美國和加拿大近 1.5% 至 1.9% 的人口患有心力衰竭。 在歐洲，1% 到 2% 的人口患有這種疾病。 此外，該文件稱，中國有1210萬患者患有心力衰竭，其中25歲以上的患者約有300萬人。 心力衰竭患者的增加導致對心臟移植的需求增加。 因此，它有望促進對心臟治療系統的需求並推動該領域的發展。 此外，根據 Elsevier 2022 年 8 月公佈的數據，到 2021 年 4 月，印度新德裡 AIIMS 已完成近 1,113 例心臟移植和 101 例心肺移植。 預計如此大量的心臟移植將促進這一細分市場的增長。

此外，各種心臟移植中心的建立預計將推動對器官護理系統 (OCS) 的需求並促進市場增長。 例如，2022年3月，亞洲醫學科學研究所（AIMS）與美高梅醫療集團合作，在北印度啟動了心肺移植中心，提供簡單快捷的器官移植服務。

心臟產品批准的增加也有望促進研究領域的增長。 例如，2022 年 4 月，Transmedics 的器官護理系統 (OCS) 獲得了美國 FDA 的批准，這是一種使用腦死亡捐獻者器官的心臟系統。

因此，預計在預測期內，大量心臟移植、心血管疾病上升、產品發布增加等將有助於研究領域的增長。

預計北美將佔據重要的市場份額

由於器官移植需求的增加和器官捐贈的增加，預計北美將佔據重要的市場份額。 此外，器官護理系統（OCS）先進技術的快速引入和主要市場參與者的存在也是北美市場的驅動因素。

例如，Organdonor.gov 於 2022 年 3 月發布的數據指出，大約有 105,800 名患者在國家移植等待名單上。 它還指出，2021 年將進行 40,000 多例移植手術。 同樣，CIHI 於 2022 年 6 月發布的數據指出，2021 年加拿大進行了 2,782 例器官移植。 如此大量的器官移植手術和不斷增長的器官移植需求預計將有助於該地區的市場增長。 器官衰竭的流行也是一個促成因素。 美國腎臟基金會 2022 年 2 月發布的數據指出，大約 81 萬美國人已經克服了腎衰竭，超過 24 萬美國人正在接受腎移植。。

同樣，北美中心的大量器官移植中心也有望促進市場的增長。 例如，2022 年 1 月發表在 AASLD 上的一篇文章提到，CENTARA 在墨西哥批准了 84 個肝移植中心。 批准的移植中心的這種增加也有望推動對器官護理系統 (OCS) 的需求。

此外，增加產品開發和批准也有望促進該地區的市場增長。 例如，2021年10月，Paragonix Technologies在美國商業化推出了LIVERgaurd Donor Liver Preservation System。 LIVERgaurd 系統為低溫肝臟保存提供了一個高度受控的、最先進的環境，並結合實時數字監控，以在整個移植過程中保護供體的肝臟。

因此，大量器官移植和不斷增長的移植手術需求，以及主要製造商的存在和頻繁的產品發布，將有助於預測期內該地區的市場增長。看來。

器官護理系統 (OCS) 市場競爭對手分析

器官護理系統 (OCS) 市場較為分散，由主要市場參與者組成。 競爭格局包括對幾家具有市場份額的知名國際和本地公司的分析。 主要市場參與者是 TransMedics 、 Xvivo Perfusion AB 、 Paragonix Technologies Inc .、 OrganOx Limited 、 Bridge to Life Ltd 等。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 調查先決條件和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 增加器官衰竭的發生率和增加器官移植
    • 技術開發進展
  • 市場製約因素
    • 缺乏對器官衰竭和器官移植費用高昂的認識
  • 行業吸引力 - 五力分析分析
    • 新進入者的威脅
    • 買家的議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按產品分類
    • 手推車
    • 便攜式
  • 按器官類型
    • 腎臟
    • 心
    • 由其他機關
  • 最終用戶
    • 醫院
    • 門診手術中心
    • 其他最終用戶
  • 按地區細分
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 世界其他地區

第六章競爭格局

  • 公司簡介
    • TransMedics
    • Xvivo Perfusion AB
    • Bridge to Life Ltd
    • Paragonix Technologies Inc.
    • OrganOx Limited
    • Preservation Solution Inc.
    • Organ assist BV
    • Water Medical System
    • Organ Recovery Systems Inc.

第7章 市場機會今後動向

簡介目錄
Product Code: 93138

The organ care system market studied is anticipated to grow with a CAGR of 9.1% during the forecast period.

The sudden outbreak of COVID-19 had a significant impact on the market. This was mainly due to the reduction of organ donation and transplantation procedures due to the cancellation of elective procedures to curb the pandemic infection. The article published in Springer in December 2021 mentioned a 21% reduction in organ donation and a 59% reduction in transplants. The source also noted that 59% of living donor kidney transplant programs suspended the evaluation of new donors due to the COVID-19 pandemic. Such reduction in organ donations and transplantation during the pandemic significantly impacted the market growth. However, the relaxation of strict regulations during the post-pandemic increased organ donations and transplant surgeries, thereby contributing to the market's growth over the forecast period.

Some significant market growth factors are the increased incidence of various chronic disorders resulting in organ failures, along with a high volume of organ transplantation surgeries. The rising technological developments are also expected to contribute to the market's growth.

Similarly, according to the data published by the British Heart Foundation in August 2022, in the United Kingdom, over 7.6 million people survived heart or circulatory disease in 2021. The World Kidney day data published in March 2022 mentioned that about 1 in 10 people worldwide have chronic kidney disease. The prevalence of various conditions resulting in organ transplantation is expected to contribute to the market's growth. Additionally, the high organ transplantation volume is expected to drive market growth. For instance, the data published by the print in May 2022 mentioned that nearly 17,000 to 18,000 solid organ transplants are performed in India each year.

Furthermore, the increasing product approvals and launches by various key market players are also expected to contribute to the market's growth. In December 2021, OrganOx received the United States FDA's premarket approval for its metra system. The metra is a fully automated NMP device for preserving and transporting donor livers destined for transplantation.

Thus, the increasing demand for organ transplantation surgeries and product approvals and developments are expected to contribute to the market's growth over the forecast period.

Organ Care Systems (OCS) Market Trends

Heart Segment Expected to Hold a Significant Market Share

The growth of the studied segment is attributed to the growing incidence of cardiovascular diseases and the increasing incidence of heart transplants among the global population.

For instance, the data published by American Heart Journal in May 2021 mentioned that almost 1.5% to 1.9% of the population suffers from heart failure in the United States and Canada. In Europe, 1% to 2% of the population suffers from the disease. The same source also stated that 12.1 million patients were suffering from heart failure in China, while in people over 25 years old, the incidence of the disease was around 3 million. Such increasing cases of heart failure are leading to the growing demand for heart transplants. This is expected to contribute to the demand for heart care systems, thereby driving the segment's growth. Furthermore, according to the data published by the Elsevier article in August 2022, nearly 1,113 heart transplants and 101 heart-lung transplants were performed at AIIMS, New Delhi, India, till April 2021. Such a high volume of heart transplants is expected to drive the segment's growth.

Also, establishing various heart transplant centers is expected to drive the demand for organ care systems, fueling the market's growth. For instance, in March 2022, the Asian Institute of Medical Sciences (AIMS) launched the Heart and lung transplant center in North India in collaboration with MGM healthcare to provide easy and fast organ transplant services.

The increasing product approvals for the heart are also expected to contribute to the growth of the studied segment. For instance, in April 2022, TransMedics, Inc. received approval from the United States FDA for its Organ Care System (OCS) heart systems for use with organs from donors after brain death.

Thus, the high volume of heart transplants, rising cardiovascular diseases, and increasing product launches are expected to contribute to the growth of the studied segment over the forecast period.

North America Expected to Hold a Significant Market Share

North America is expected to hold a significant market share owing to the rising demand for organ transplantations and increasing organ donation. Additionally, the quick adoption of advanced technologies in the organ's care systems and the presence of key market players are driving factors for the North American market.

For instance, the data published by Organdonor.gov in March 2022 mentioned that nearly 105,800 patients were on the national transplant waiting list. The report also noted that more than 40,000 transplants were performed in 2021. Similarly, the CIHI data published in June 2022 mentioned that 2,782 organ transplants were performed in Canada in 2021. Such a high volume of organ transplant surgeries and increasing demand for organ transplantations are expected to contribute to the region's market growth. The prevalence of organ failure is another contributing factor. The data published by American Kidney Fund in February 2022 mentioned that nearly 810,000 Americans survive kidney failure, and over 240,00 Americans live with kidney transplants.

Likewise, the high number of organ transplant centers in North American centers is also expected to contribute to the growth of the market. For instance, the article published in AASLD in January 2022 mentioned that CENTARA had approved 84 centers in Mexico for liver transplants. Such growth in approved transplant centers is also expected to drive the demand for organ care systems.

Furthermore, the increasing product developments and approvals are also expected to contribute to the market growth in this region. For instance, in October 2021, Paragonix Technologies commercially launched the LIVERgaurd Donor Liver Preservation System in the United States. The LIVERgaurd System provides a highly controlled, state-of-the-art environment for hypothermic liver preservation, coupled with real-time digital monitoring to safeguard a donor's liver throughout the transplant process.

Thus, the high volume of organ transplantations and increasing demand for transplant surgeries, along with the presence of key players and frequent product launches, are expected to contribute to the market growth in this region over the forecast period.

Organ Care Systems (OCS) Market Competitor Analysis

The organ care system market is moderately fragmented and consists of major market players. The competitive landscape includes an analysis of a few international as well as local companies which hold market shares and are well-known. The major market players are TransMedics, Xvivo Perfusion AB, Paragonix Technologies Inc., OrganOx Limited, Bridge to Life Ltd, and others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope Of The Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Incidence of Organ Failures and Rising Organ Transplantations
    • 4.2.2 Increasing Technological Developments
  • 4.3 Market Restraints
    • 4.3.1 Lack of Awareness Regarding Organ Failure and High Cost for Organ Transplantation
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Trolley
    • 5.1.2 Portable
  • 5.2 By Organ Type
    • 5.2.1 Kidney
    • 5.2.2 Heart
    • 5.2.3 Other Organ Types
  • 5.3 By End-user
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Other End-users
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of the Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of the Asia-Pacific
    • 5.4.4 Rest of the World

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 TransMedics
    • 6.1.2 Xvivo Perfusion AB
    • 6.1.3 Bridge to Life Ltd
    • 6.1.4 Paragonix Technologies Inc.
    • 6.1.5 OrganOx Limited
    • 6.1.6 Preservation Solution Inc.
    • 6.1.7 Organ assist BV
    • 6.1.8 Water Medical System
    • 6.1.9 Organ Recovery Systems Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS